§
Cui Bono
Bills Search Find My Rep Legislators Who Benefits Countries Methodology

HR1597-118

Introduced

To amend the Controlled Substances Act with respect to a penalty for illicit fentanyl and fentanyl-related substances.

118th Congress Introduced Mar 14, 2023

Summary

What This Bill Does

The bill requires enhanced penalty for illicit fentanyl and fentanyl-related substances Part D of title II of the Controlled Substances Act (21 U.S.C and requires penalty with respect to illicit fentanyl and fentanyl-related substances It shall be unlawful for any person to sell, give, or distribute any substance that contains two milligrams or more of— illicit fentanyl. It relies on definition changes, compliance mandates, exemptions, and delegation of rulemaking. The main policy areas are Healthcare Consumers and Healthcare.

Who Benefits and How

Patients and health care consumers affected by the bill could face lower compliance burdens.

Who Bears the Burden and How

Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Public beneficiaries or protected communities affected by the clause could face increased risk.

Key Provisions

  • Requires enhanced penalty for illicit fentanyl and fentanyl-related substances Part D of title II of the Controlled Substances Act (21 U.S.C.
  • Requires penalty with respect to illicit fentanyl and fentanyl-related substances It shall be unlawful for any person to sell, give, or distribute any substance that contains two milligrams or more of— illicit fentanyl.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill requires enhanced penalty for illicit fentanyl and fentanyl-related substances Part D of title II of the Controlled Substances Act (21 U.S.C and requires penalty with respect to illicit fentanyl and fentanyl-related substances It shall be unlawful for any person to sell, give, or distribute any substance that contains two milligrams or more of— illicit fentanyl.

Key Policy Areas

Healthcare Consumers, Healthcare

Primary Purpose

The bill requires enhanced penalty for illicit fentanyl and fentanyl-related substances Part D of title II of the Controlled Substances Act (21 U.S.C and requires penalty with respect to illicit fentanyl and fentanyl-related substances It shall be unlawful for any person to sell, give, or distribute any substance that contains two milligrams or more of— illicit fentanyl.

Policy Domains

Healthcare Consumers Healthcare

Whole bill

Identified Gains
  • Patients and health care consumers affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Patients and health care consumers affected by the bill: ,
Identified Costs
  • Federal, state, or local agencies responsible for implementing the clause
  • Public beneficiaries or protected communities affected by the clause
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: ih
Public beneficiaries or protected communities affected by the clause: ,
Federal, state, or local agencies responsible for implementing the clause: ,

Sponsors

Dan Newhouse

Dan Newhouse

R-WA | Primary Sponsor

1 cosponsor

Legislative Progress

Introduced
Introduced Committee Passed
Mar 14, 2023

Mr. Newhouse (for himself and Mr. Moore of Alabama) introduced …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Consumers Healthcare

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology